![Sanj Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sanj Patel
Grundare på
Sarcoma Foundation of America
Förmögenhet: 85 M $ per 2026-05-31
Profil
Sanj K.
Patel is the founder of Kiniksa Pharmaceuticals Ltd., founded in 2015, serving as Chairman & Chief Executive Officer.
Mr. Patel is the founder of Sarcoma Foundation of America, founded in 2015, serving as Director.
Current jobs include Chairman & Chief Executive Officer at Kiniksa Pharmaceuticals International Plc since 2024 and President at Kiniksa Pharmaceuticals Corp.
Former jobs include President, Chief Executive Officer & Director at Synageva BioPharma Corp.
from 2008 to 2015; Independent Director at BioCryst Pharmaceuticals, Inc. from 2015 to 2018; Independent Director at Intercept Pharmaceuticals, Inc. from 2014 to 2015; Independent Director at Syros Pharmaceuticals, Inc. from 2016 to 2018; and Head-Global Clinical Research Operations Council at Genzyme Corp.
from 1999 to 2008.
Education includes undergraduate studies at London South Bank University and graduate studies at Ealing Hammersmith & West London College.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
2,46 % | 2026-06-01 | 1 137 763 ( 2,46 % ) | 55 M $ | 2026-05-31 |
15,25 % | 2026-06-01 | 626 160 ( 15,25 % ) | 30 M $ | 2026-05-31 |
Aktiva positioner av Sanj Patel
| Företag | Position | Start |
|---|---|---|
Sarcoma Foundation of America
 Sarcoma Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Grundare | 2015-01-01 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Verkställande Direktör | 2015-01-01 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | President | - |
Tidigare kända positioner av Sanj Patel
| Företag | Position | Slut |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2018-06-20 |
| SYROS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2018-06-14 |
| INTERCEPT PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2015-11-24 |
| SYNAGEVA BIOPHARMA CORP | Verkställande Direktör | 2015-06-22 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | 2008-01-01 |
Sanj Patels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
70
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
London South Bank University
 London South Bank University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Sarcoma Foundation of America
Sarcoma Foundation of America Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Ealing Hammersmith & West London College
 Ealing Hammersmith & West London College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
![\"G](\"https://www.zonebourse.com/images/ImagesTagged/GD/2026/google/Google__G__logo.svg\"){kind=logo}
Välj MarketScreener 
